Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.

The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Abstract Text:

    paul n newtonPaul N Newton,karen i barnesKaren I Barnes,peter j smithPeter J Smith,alicia c evansAlicia C Evans,wirongrong chierakulWirongrong Chierakul,ronatrai ruangveerayuthRonatrai Ruangveerayuth,nicholas j whiteNicholas J White,paul n newtonPaul N Newton,karen i barnesKaren I Barnes,peter j smithPeter J Smith,alicia c evansAlicia C Evans,wirongrong chierakulWirongrong Chierakul,ronatrai ruangveerayuthRonatrai Ruangveerayuth,nicholas j whiteNicholas J White,

    OBJECTIVE: Intravenous artesunate is commonly used in the emergency treatment of patients with severe falciparum malaria in Asia. The choice of doses used has been empirical. To inform dosage recommendations we assessed the pharmacokinetics of intravenous artesunate after the first dose. METHODS: As part of a clinical trial of artesunate in adults with severe falciparum malaria in western Thailand, we assayed plasma concentrations of artesunate and the principal biologically active metabolite dihydroartemisinin (DHA) in 17 patients given an initial dose of 2.4 mg/kg body weight of intravenous artesunate. Drug levels were measured using high performance liquid chromatography with mass spectroscopy-electrospray ionisation detection. RESULTS: Median (range) observed DHA Cmax was 2128 (513-5789) nmol/L, elimination half-life was 0.34 (0.14-0.87) h, and the time to the last detectable DHA was 2 h. CONCLUSION: The large inter-individual variability (10 fold) in DHA Cmax and AUC in patients with potentially lethal, severe malaria, suggests that 2.4 mg/kg should be the minimum daily dose in severe malaria.

    The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Publishing Authors By Initials

    pn newtonPN Newton,ki barnesKI Barnes,pj smithPJ Smith,ac evansAC Evans,w chierakulW Chierakul,r ruangveerayuthR Ruangveerayuth,nj whiteNJ White,pn newtonPN Newton,ki barnesKI Barnes,pj smithPJ Smith,ac evansAC Evans,w chierakulW Chierakul,r ruangveerayuthR Ruangveerayuth,nj whiteNJ White,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: European journal of clinical pharmacology

    VOLUME: 62

    Page Numbers: 1003-9

    Journal Abbreviation: Eur. J. Clin. Pharmacol.

    ISSN: 0031-6970

    DAY: 7

    MONTH: 11

    YEAR: 2006

    The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1256165

    The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria.

    AFFILIATION: Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Rd., Bangkok 10400, Thailand.

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY: United Kingdom Wellcome T

    GRANT:

    ACRONYM:

    MEDLINETA: Eur J Clin Pharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The pharmacokinetics of intravenous artesunate in adults with severe falciparum malaria Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News